FDA 483 - Brian Flowers - March 23, 2023

An FDA inspection of Brian Flowers, a clinical investigator in Fort Worth, TX, revealed a significant deviation from the investigational plan. The site failed to properly monitor and report temperature excursions for study medication, resulting in two subjects receiving investigational product that was not stored under appropriate conditions. This indicates a failure to adhere to protocol requirements for clinical investigations.